Although activation of natural killer (NK) cytotoxicity is generally inhibited by target major histocompatibility complex (MHC) class I expression, subtle features of NK allorecognition suggest that NK cells possess receptors that are also activated by target MHC I. The mouse Ly-49D receptor is structurally not an inhibitory receptor and thus our studies have been focused on the ability of select Ly-49 receptors to activate NK cytotoxicity and function. Since Ly-49D does not become tyrosine phosphorylated upon activation, we have demonstrated that specific Ab cross-linking, coprecipitates a 16-kDa tyrosine- phosphorylated protein (pp16), that was cloned in the human and is termed DAP12. Association of DAP12 with Ly-49D involves a transmembrane arginine since mutation to leucine (Ly-49D[R54L]) abolishes association with pp16 in transfected P815 cells. In addition, Ly-49D(R54L) transfectants fail to mediate Ca2+ mobilization following Ab cross- linking. Therefore, signaling through Ly-49D on NK cells depends on association with a distinct tyrosine phosphoprotein (pp16) in a manner analogous to that of TCR and FcR. Expression of this novel signaling peptide in both the NK and myeloid lineages indicates that pp16 is likely involved in the signal transduction cascade of additional receptor families. To define Ly-49D-ligand interactions, we utilized both transfected rat NK cell lines and primary mouse subests. RNK-16 expressing Ly-49D (RNK.mLy-49D) were tested against YB2/0 targets transfected with the mouse MHC I alleles H-2Dd, Db, Kk, or Kb. RNK.mLy- 49D cells lysed YB2/0. Dd targets more efficiently than untransfected YB2/0 or YB2/0 transfected with Db, Kk, or Kb and this augmented lysis was specifically inhibited by F(ab)2 anti-Ly-49D and F(ab)2 anti-H-2Dd (34-5-8S). RNK.mLy-49D effectors were also able to specifically lyse Concanavalin A blasts isolated from H-2(d) mice (BALB/c, B10.D2, and DBA/2) but not from H-2(b) or H-2(k) mice. Primary cells were analyzed using sorted NK cell subsets as effectors and a panel of 51Cr- labeled Con A lymphoblasts as targets in the presence or the absence of Abs to Ly49 and/or class I molecules. Our results demonstrate that the activating receptor Ly49D delivers stimulatory signals for target cell lysis upon interacting with H2-Dd, Dr, and Dsp2, but not H2b or H2k class I Ags. Thus, lysis of class I MHC-bearing targets by NK cells is not merely the consequence of the absence of an Ly49-mediated negative signal, but also requires positive recognition of class I molecules by certain Ly-49 receptors. Activation of NK cells by nonself class I molecules was not predicted by the missing self hypothesis. NK cells mediate the specific rejection of bone marrow cell (BMC) allografts in lethally irradiated mice. Depletion of Ly-49D+ NK cells in H-2b mice abrogated their ability to reject H-2d BMC allografts. Similarly, Ly- 49C+ NK cells also were shown to mediate the specific rejection of H-2d BMC. When both subsets were depleted, an additive enhancement of BMC engraftment was observed, indicating that both subsets play a role in the rejection of allogeneic H-2-homozygous H-2d BMC. However, rejection of H-2(b x d) or D8 (H-2b, Dd transgene) BMC allografts was unaffected by Ly-49C+ NK cell depletion in H-2b mice. In marked contrast, depletion of Ly-49D+ NK cells in H-2b mice totally abrogated the rejection of H-2(b x d) heterozygous BMC in support of in vitro data suggesting that Ly-49D+ NK cells receive activating signals. Therefore, NK subsets demonstrate a differential ability to reject H-2 homozygous and heterozygous BMC. - Class I, Ly-, , mouse, NK, receptor, regulation,

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC009247-19
Application #
6289234
Study Section
Special Emphasis Panel (LEI)
Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Ortaldo, John R; Winkler-Pickett, Robin T; Bere Jr, Earl W et al. (2005) In vivo hydrodynamic delivery of cDNA encoding IL-2: rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells. J Immunol 175:693-9
Ortaldo, John R; Young, Howard A (2005) Mouse Ly49 NK receptors: balancing activation and inhibition. Mol Immunol 42:445-50
Ortaldo, John R; Young, Howard A; Winkler-Pickett, Robin T et al. (2004) Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J Immunol 172:943-53
Mason, Llewellyn H; Willette-Brown, Jami; Anderson, Stephen K et al. (2003) Receptor glycosylation regulates Ly-49 binding to MHC class I. J Immunol 171:4235-42
Ortaldo, John R; Young, Howard A (2003) Expression of IFN-gamma upon triggering of activating Ly49D NK receptors in vitro and in vivo: costimulation with IL-12 or IL-18 overrides inhibitory receptors. J Immunol 170:1763-9
Raziuddin, A; Bennett, M; Winkler-Pickett, R et al. (2000) Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts. Blood 95:3840-4
Peacock, C D; Lin, M Y; Ortaldo, J R et al. (2000) The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J Virol 74:7032-8
Mason, L H; Willette-Brown, J; Mason, A T et al. (2000) Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion. J Immunol 164:603-11
Bosco, M C; Curiel, R E; Zea, A H et al. (2000) IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck. J Immunol 164:4575-85
Ortaldo, J R; Winkler-Pickett, R; Wiegand, G (2000) Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors. J Leukoc Biol 68:748-56

Showing the most recent 10 out of 20 publications